ID   EST1_HUMAN              Reviewed;         567 AA.
AC   P23141; A6NIM1; A8K3K8; A8K844; E9PAU8; P82127; Q00015; Q13657;
AC   Q14062; Q16737; Q16788; Q549X7; Q549X8; Q86UK2; Q96EE8; Q9UC52;
AC   Q9UDG8; Q9UK77; Q9ULY2;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1992, sequence version 2.
DT   10-MAY-2017, entry version 181.
DE   RecName: Full=Liver carboxylesterase 1;
DE   AltName: Full=Acyl-coenzyme A:cholesterol acyltransferase;
DE            Short=ACAT;
DE   AltName: Full=Brain carboxylesterase hBr1;
DE   AltName: Full=Carboxylesterase 1;
DE            Short=CE-1;
DE            Short=hCE-1;
DE            EC=3.1.1.1 {ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:9169443, ECO:0000269|PubMed:9490062};
DE   AltName: Full=Cocaine carboxylesterase;
DE   AltName: Full=Egasyn;
DE   AltName: Full=HMSE;
DE   AltName: Full=Methylumbelliferyl-acetate deacetylase 1;
DE            EC=3.1.1.56 {ECO:0000269|PubMed:9169443};
DE   AltName: Full=Monocyte/macrophage serine esterase;
DE   AltName: Full=Retinyl ester hydrolase;
DE            Short=REH;
DE   AltName: Full=Serine esterase 1;
DE   AltName: Full=Triacylglycerol hydrolase;
DE            Short=TGH;
DE   Flags: Precursor;
GN   Name=CES1; Synonyms=CES2, SES1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1918003;
RA   Munger J.S., Shi G.P., Mark E.A., Chin D.T., Gerard C., Chapman H.A.;
RT   "A serine esterase released by human alveolar macrophages is closely
RT   related to liver microsomal carboxylesterases.";
RL   J. Biol. Chem. 266:18832-18838(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Liver;
RX   PubMed=8218228; DOI=10.1021/bi00094a018;
RA   Kroetz D.L., McBride O.W., Gonzalez F.J.;
RT   "Glycosylation-dependent activity of baculovirus-expressed human liver
RT   carboxylesterases: cDNA cloning and characterization of two highly
RT   similar enzyme forms.";
RL   Biochemistry 32:11606-11617(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Peripheral blood, and Placenta;
RX   PubMed=8406473; DOI=10.1006/geno.1993.1285;
RA   Shibata F., Takagi Y., Kitajima M., Kuroda T., Omura T.;
RT   "Molecular cloning and characterization of a human carboxylesterase
RT   gene.";
RL   Genomics 17:76-82(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=8049197;
RA   Becker A., Bottcher A., Lackner K.J., Fehringer P., Notka F.,
RA   Aslanidis C., Schmitz G.;
RT   "Purification, cloning, and expression of a human enzyme with acyl
RT   coenzyme A: cholesterol acyltransferase activity, which is identical
RT   to liver carboxylesterase.";
RL   Arterioscler. Thromb. 14:1346-1355(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND INTERACTION WITH BETA-GLUCURONIDASE.
RC   TISSUE=Liver;
RX   PubMed=10562416; DOI=10.1006/abbi.1999.1449;
RA   Islam M.R., Waheed A., Shah G.N., Tomatsu S., Sly W.S.;
RT   "Human egasyn binds beta-glucuronidase but neither the esterase active
RT   site of egasyn nor the C-terminus of beta-glucuronidase is involved in
RT   their interaction.";
RL   Arch. Biochem. Biophys. 372:53-61(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Macrophage;
RX   PubMed=11015575;
RA   Ghosh S.;
RT   "Cholesteryl ester hydrolase in human monocyte/macrophage: cloning,
RT   sequencing, and expression of full-length cDNA.";
RL   Physiol. Genomics 2:1-8(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PROTEIN SEQUENCE OF 19-28.
RC   TISSUE=Liver;
RX   PubMed=11812220; DOI=10.1006/prep.2001.1553;
RA   Alam M., Ho S., Vance D.E., Lehner R.;
RT   "Heterologous expression, purification, and characterization of human
RT   triacylglycerol hydrolase.";
RL   Protein Expr. Purif. 24:33-42(2002).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RA   Hosokawa M., Yaginuma Y., Watanabe N., Yamamoto N., Tsukada E.,
RA   Ohhata Y., Satoh T., Chiba K.;
RT   "Inverted duplication of human carboxylesterase 1(CES1) genes, which
RT   are difference in regulation at the transcriptional level.";
RL   Submitted (SEP-2003) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Esophagus, and Heart;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Blood, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-429 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10518925; DOI=10.1016/S0014-5793(99)01111-4;
RA   Mori M., Hosokawa M., Ogasawara Y., Tsukada E., Chiba K.;
RT   "cDNA cloning, characterization and stable expression of novel human
RT   brain carboxylesterase.";
RL   FEBS Lett. 458:17-22(1999).
RN   [13]
RP   PROTEIN SEQUENCE OF 18-27; 37-52; 65-75; 187-198; 258-273; 288-298;
RP   314-319; 340-352; 377-382; 439-461; 463-473; 499-504; 506-514 AND
RP   539-557, FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES,
RP   AND SUBUNIT.
RC   TISSUE=Liver;
RX   PubMed=7980644; DOI=10.1016/0006-2952(94)90461-8;
RA   Brzezinski M.R., Abraham T.L., Stone C.L., Dean R.A., Bosron W.F.;
RT   "Purification and characterization of a human liver cocaine
RT   carboxylesterase that catalyzes the production of benzoylecgonine and
RT   the formation of cocaethylene from alcohol and cocaine.";
RL   Biochem. Pharmacol. 48:1747-1755(1994).
RN   [14]
RP   PROTEIN SEQUENCE OF 18-28; 65-78; 93-107; 243-255; 258-266; 297-313
RP   AND 341-346, CATALYTIC ACTIVITY, ENZYME REGULATION, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RC   TISSUE=Liver;
RX   PubMed=9490062; DOI=10.1046/j.1432-1327.1998.2510863.x;
RA   Schindler R., Mentlein R., Feldheim W.;
RT   "Purification and characterization of retinyl ester hydrolase as a
RT   member of the non-specific carboxylesterase supergene family.";
RL   Eur. J. Biochem. 251:863-873(1998).
RN   [15]
RP   PROTEIN SEQUENCE OF 19-34, NUCLEOTIDE SEQUENCE [MRNA] OF 113-121;
RP   138-149; 216-224; 351-357 AND 466-471, AND SUBUNIT.
RC   TISSUE=Liver;
RX   PubMed=8597091; DOI=10.1016/0378-4274(95)03493-5;
RA   Satoh T., Hosokawa M.;
RT   "Molecular aspects of carboxylesterase isoforms in comparison with
RT   other esterases.";
RL   Toxicol. Lett. 82:439-445(1995).
RN   [16]
RP   PROTEIN SEQUENCE OF 19-28, ACTIVE SITES, GLYCOSYLATION AT ASN-79, AND
RP   MUTAGENESIS OF ASN-79; SER-221; GLU-354; HIS-468 AND 564-HIS--LEU-567.
RX   PubMed=12022871; DOI=10.1021/bi0255625;
RA   Alam M., Vance D.E., Lehner R.;
RT   "Structure-function analysis of human triacylglycerol hydrolase by
RT   site-directed mutagenesis: identification of the catalytic triad and a
RT   glycosylation site.";
RL   Biochemistry 41:6679-6687(2002).
RN   [17]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 61-567.
RC   TISSUE=Liver;
RX   PubMed=1997784; DOI=10.1016/0024-3205(91)90515-D;
RA   Long R.M., Calabrese M.R., Martin B.M., Pohl L.R.;
RT   "Cloning and sequencing of a human liver carboxylesterase isoenzyme.";
RL   Life Sci. 48:PL43-PL49(1991).
RN   [18]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 64-567, AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=2070086;
RA   Zschunke F., Salmassi A., Kreipe H., Buck F., Parwaresch M.R.,
RA   Radzun H.J.;
RT   "cDNA cloning and characterization of human monocyte/macrophage serine
RT   esterase-1.";
RL   Blood 78:506-512(1991).
RN   [19]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 114-567.
RC   TISSUE=Liver;
RX   PubMed=1748313; DOI=10.1016/0378-1119(91)90448-K;
RA   Riddles P.W., Richards L.J., Bowles M.R., Pond S.M.;
RT   "Cloning and analysis of a cDNA encoding a human liver
RT   carboxylesterase.";
RL   Gene 108:289-292(1991).
RN   [20]
RP   FUNCTION AS METHYLUMBELLIFERYL-ACETATE DEACETYLASE, CATALYTIC
RP   ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=9169443; DOI=10.1074/jbc.272.23.14769;
RA   Pindel E.V., Kedishvili N.Y., Abraham T.L., Brzezinski M.R., Zhang J.,
RA   Dean R.A., Bosron W.F.;
RT   "Purification and cloning of a broad substrate specificity human liver
RT   carboxylesterase that catalyzes the hydrolysis of cocaine and
RT   heroin.";
RL   J. Biol. Chem. 272:14769-14775(1997).
RN   [21]
RP   BIOPHYSICOCHEMICAL PROPERTIES, VARIANT GLU-143, AND CHARACTERIZATION
RP   OF VARIANT GLU-143.
RX   PubMed=18485328; DOI=10.1016/j.ajhg.2008.04.015;
RA   Zhu H.-J., Patrick K.S., Yuan H.-J., Wang J.-S., Donovan J.L.,
RA   DeVane C.L., Malcolm R., Johnson J.A., Youngblood G.L., Sweet D.H.,
RA   Langaee T.Y., Markowitz J.S.;
RT   "Two CES1 gene mutations lead to dysfunctional carboxylesterase 1
RT   activity in man: clinical significance and molecular basis.";
RL   Am. J. Hum. Genet. 82:1241-1248(2008).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-380, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) IN COMPLEX WITH SUBSTRATE.
RX   PubMed=12725862; DOI=10.1016/S1074-5521(03)00071-1;
RA   Bencharit S., Morton C.L., Hyatt J.L., Kuhn P., Danks M.K.,
RA   Potter P.M., Redinbo M.R.;
RT   "Crystal structure of human carboxylesterase 1 complexed with the
RT   Alzheimer's drug tacrine. From binding promiscuity to selective
RT   inhibition.";
RL   Chem. Biol. 10:341-349(2003).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) IN COMPLEX WITH SUBSTRATES.
RX   PubMed=12679808; DOI=10.1038/nsb919;
RA   Bencharit S., Morton C.L., Xue Y., Potter P.M., Redinbo M.R.;
RT   "Structural basis of heroin and cocaine metabolism by a promiscuous
RT   human drug-processing enzyme.";
RL   Nat. Struct. Biol. 10:349-356(2003).
CC   -!- FUNCTION: Involved in the detoxification of xenobiotics and in the
CC       activation of ester and amide prodrugs. Hydrolyzes aromatic and
CC       aliphatic esters, but has no catalytic activity toward amides or a
CC       fatty acyl-CoA ester. Hydrolyzes the methyl ester group of cocaine
CC       to form benzoylecgonine. Catalyzes the transesterification of
CC       cocaine to form cocaethylene. Displays fatty acid ethyl ester
CC       synthase activity, catalyzing the ethyl esterification of oleic
CC       acid to ethyloleate. {ECO:0000269|PubMed:7980644,
CC       ECO:0000269|PubMed:9169443}.
CC   -!- CATALYTIC ACTIVITY: A carboxylic ester + H(2)O = an alcohol + a
CC       carboxylate. {ECO:0000255|PROSITE-ProRule:PRU10039,
CC       ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:9169443,
CC       ECO:0000269|PubMed:9490062}.
CC   -!- CATALYTIC ACTIVITY: 4-methylumbelliferyl acetate + H(2)O = 4-
CC       methylumbelliferone + acetate. {ECO:0000269|PubMed:9169443}.
CC   -!- ENZYME REGULATION: Activated by CHAPS.
CC       {ECO:0000269|PubMed:9490062}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=106.6 uM for p-nitrophenyl acetate
CC         {ECO:0000269|PubMed:18485328, ECO:0000269|PubMed:7980644,
CC         ECO:0000269|PubMed:9169443, ECO:0000269|PubMed:9490062};
CC         KM=775.7 uM for L-methylphenidate {ECO:0000269|PubMed:18485328,
CC         ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:9169443,
CC         ECO:0000269|PubMed:9490062};
CC         KM=663.5 uM for D-methylphenidate {ECO:0000269|PubMed:18485328,
CC         ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:9169443,
CC         ECO:0000269|PubMed:9490062};
CC         KM=116 uM for cocaine {ECO:0000269|PubMed:18485328,
CC         ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:9169443,
CC         ECO:0000269|PubMed:9490062};
CC         KM=43 mM for ethanol {ECO:0000269|PubMed:18485328,
CC         ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:9169443,
CC         ECO:0000269|PubMed:9490062};
CC         KM=0.8 mM for 4-methylumbelliferyl acetate
CC         {ECO:0000269|PubMed:18485328, ECO:0000269|PubMed:7980644,
CC         ECO:0000269|PubMed:9169443, ECO:0000269|PubMed:9490062};
CC         KM=6.3 mM for heroin {ECO:0000269|PubMed:18485328,
CC         ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:9169443,
CC         ECO:0000269|PubMed:9490062};
CC         KM=8.3 mM for 6-monoacetylmorphine {ECO:0000269|PubMed:18485328,
CC         ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:9169443,
CC         ECO:0000269|PubMed:9490062};
CC         Vmax=493.9 nmol/min/mg enzyme with p-nitrophenyl acetate as
CC         substrate {ECO:0000269|PubMed:18485328,
CC         ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:9169443,
CC         ECO:0000269|PubMed:9490062};
CC         Vmax=1701.1 pmol/min/mg enzyme with L-methylphenidate as
CC         substrate {ECO:0000269|PubMed:18485328,
CC         ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:9169443,
CC         ECO:0000269|PubMed:9490062};
CC         Vmax=177.2 pmol/min/mg enzyme with D-methylphenidate as
CC         substrate {ECO:0000269|PubMed:18485328,
CC         ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:9169443,
CC         ECO:0000269|PubMed:9490062};
CC       pH dependence:
CC         Optimum pH is 6.5. {ECO:0000269|PubMed:18485328,
CC         ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:9169443,
CC         ECO:0000269|PubMed:9490062};
CC   -!- SUBUNIT: Homotrimer and homohexamer. Binds to beta-glucuronidase.
CC       {ECO:0000269|PubMed:12679808, ECO:0000269|PubMed:12725862,
CC       ECO:0000269|PubMed:7980644, ECO:0000269|PubMed:8597091}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen
CC       {ECO:0000269|PubMed:10562416}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P23141-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P23141-2; Sequence=VSP_021026;
CC       Name=3;
CC         IsoId=P23141-3; Sequence=VSP_047158;
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in liver with lower
CC       levels in heart and lung. {ECO:0000269|PubMed:10562416}.
CC   -!- PTM: Contains sialic acid.
CC   -!- PTM: Cleavage of the signal sequence can occur at 2 positions,
CC       either between Trp-17 and Gly-18 or between Gly-18 and His-19.
CC   -!- SIMILARITY: Belongs to the type-B carboxylesterase/lipase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA83932.1; Type=Frameshift; Positions=301, 312, 318, 383, 391; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M73499; AAA35649.1; -; mRNA.
DR   EMBL; L07764; AAA16036.1; -; mRNA.
DR   EMBL; L07765; AAA35711.1; -; mRNA.
DR   EMBL; D21088; BAA04650.1; -; Genomic_DNA.
DR   EMBL; S73751; AAC60631.2; -; mRNA.
DR   EMBL; AF177775; AAD53175.1; -; mRNA.
DR   EMBL; AY268104; AAP20868.1; -; mRNA.
DR   EMBL; AB119995; BAC87748.1; -; mRNA.
DR   EMBL; AB119996; BAC87749.1; -; mRNA.
DR   EMBL; AB119997; BAC87750.1; -; Genomic_DNA.
DR   EMBL; AB119998; BAC87751.1; -; Genomic_DNA.
DR   EMBL; AK290623; BAF83312.1; -; mRNA.
DR   EMBL; AK292209; BAF84898.1; -; mRNA.
DR   EMBL; AC147362; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC012418; AAH12418.1; -; mRNA.
DR   EMBL; BC110338; AAI10339.1; -; mRNA.
DR   EMBL; AB025026; BAA84995.1; -; mRNA.
DR   EMBL; M55509; AAA35650.1; -; mRNA.
DR   EMBL; X52973; CAA37147.1; -; mRNA.
DR   EMBL; M65261; AAA83932.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS32450.1; -. [P23141-2]
DR   CCDS; CCDS45488.1; -. [P23141-1]
DR   CCDS; CCDS45489.1; -. [P23141-3]
DR   PIR; A41010; A41010.
DR   RefSeq; NP_001020365.1; NM_001025194.1. [P23141-1]
DR   RefSeq; NP_001020366.1; NM_001025195.1. [P23141-2]
DR   RefSeq; NP_001257.4; NM_001266.4. [P23141-3]
DR   UniGene; Hs.558865; -.
DR   PDB; 1MX1; X-ray; 2.40 A; A/B/C/D/E/F=19-567.
DR   PDB; 1MX5; X-ray; 2.80 A; A/B/C/D/E/F=19-567.
DR   PDB; 1MX9; X-ray; 2.90 A; A/B/C/D/E/F/G/H/I/J/K/L=19-567.
DR   PDB; 1YA4; X-ray; 3.20 A; A/B/C=21-552.
DR   PDB; 1YA8; X-ray; 3.00 A; A/B/C=21-552.
DR   PDB; 1YAH; X-ray; 3.00 A; A/B/C=21-552.
DR   PDB; 1YAJ; X-ray; 3.20 A; A/B/C/D/E/F/G/H/I/J/K/L=21-552.
DR   PDB; 2DQY; X-ray; 3.00 A; A/B/C=19-561.
DR   PDB; 2DQZ; X-ray; 2.80 A; A/B/C=19-561.
DR   PDB; 2DR0; X-ray; 3.20 A; A/B/C=19-561.
DR   PDB; 2H7C; X-ray; 2.00 A; A/B/C/D/E/F=19-561.
DR   PDB; 2HRQ; X-ray; 2.70 A; A/B/C/D/E/F=21-553.
DR   PDB; 2HRR; X-ray; 2.70 A; A/B/C=21-553.
DR   PDB; 3K9B; X-ray; 3.10 A; A/B/C=24-553.
DR   PDB; 4AB1; X-ray; 2.20 A; A=21-553.
DR   PDB; 5A7F; X-ray; 1.86 A; A=21-553.
DR   PDB; 5A7G; X-ray; 1.48 A; A=21-553.
DR   PDB; 5A7H; X-ray; 2.01 A; A=22-553.
DR   PDBsum; 1MX1; -.
DR   PDBsum; 1MX5; -.
DR   PDBsum; 1MX9; -.
DR   PDBsum; 1YA4; -.
DR   PDBsum; 1YA8; -.
DR   PDBsum; 1YAH; -.
DR   PDBsum; 1YAJ; -.
DR   PDBsum; 2DQY; -.
DR   PDBsum; 2DQZ; -.
DR   PDBsum; 2DR0; -.
DR   PDBsum; 2H7C; -.
DR   PDBsum; 2HRQ; -.
DR   PDBsum; 2HRR; -.
DR   PDBsum; 3K9B; -.
DR   PDBsum; 4AB1; -.
DR   PDBsum; 5A7F; -.
DR   PDBsum; 5A7G; -.
DR   PDBsum; 5A7H; -.
DR   ProteinModelPortal; P23141; -.
DR   SMR; P23141; -.
DR   BioGrid; 107494; 3.
DR   IntAct; P23141; 8.
DR   MINT; MINT-5004142; -.
DR   STRING; 9606.ENSP00000353720; -.
DR   BindingDB; P23141; -.
DR   ChEMBL; CHEMBL2265; -.
DR   DrugBank; DB03056; 4-Piperidino-Piperidine.
DR   DrugBank; DB01086; Benzocaine.
DR   DrugBank; DB01101; Capecitabine.
DR   DrugBank; DB02659; Cholic Acid.
DR   DrugBank; DB01410; Ciclesonide.
DR   DrugBank; DB00758; Clopidogrel.
DR   DrugBank; DB04838; Cyclandelate.
DR   DrugBank; DB06695; Dabigatran etexilate.
DR   DrugBank; DB02161; Hydroxy-Phenyl-Acetic Acid 8-Methyl-8-Aza-Bicyclo[3.2.1]Oct-3-Yl Ester.
DR   DrugBank; DB00328; Indomethacin.
DR   DrugBank; DB00762; Irinotecan.
DR   DrugBank; DB00583; L-Carnitine.
DR   DrugBank; DB06693; Mevastatin.
DR   DrugBank; DB00688; Mycophenolate mofetil.
DR   DrugBank; DB03721; N-acetyl-alpha-neuraminic acid.
DR   DrugBank; DB04509; N-Methylnaloxonium.
DR   DrugBank; DB00198; Oseltamivir.
DR   DrugBank; DB01599; Probucol.
DR   DrugBank; DB06201; Rufinamide.
DR   DrugBank; DB11362; Selexipag.
DR   DrugBank; DB00675; Tamoxifen.
DR   DrugBank; DB04795; Thenoyltrifluoroacetone.
DR   DrugBank; DB00519; Trandolapril.
DR   GuidetoPHARMACOLOGY; 2592; -.
DR   SwissLipids; SLP:000001265; -.
DR   ESTHER; human-CES1; Carb_B_Chordata.
DR   MEROPS; S09.982; -.
DR   iPTMnet; P23141; -.
DR   PhosphoSitePlus; P23141; -.
DR   BioMuta; CES1; -.
DR   DMDM; 119576; -.
DR   MaxQB; P23141; -.
DR   PaxDb; P23141; -.
DR   PeptideAtlas; P23141; -.
DR   PRIDE; P23141; -.
DR   DNASU; 1066; -.
DR   Ensembl; ENST00000360526; ENSP00000353720; ENSG00000198848. [P23141-2]
DR   Ensembl; ENST00000361503; ENSP00000355193; ENSG00000198848. [P23141-1]
DR   Ensembl; ENST00000422046; ENSP00000390492; ENSG00000198848. [P23141-3]
DR   Ensembl; ENST00000571922; ENSP00000460045; ENSG00000262243.
DR   Ensembl; ENST00000574513; ENSP00000461208; ENSG00000262243.
DR   Ensembl; ENST00000576783; ENSP00000458586; ENSG00000262243.
DR   GeneID; 1066; -.
DR   KEGG; hsa:1066; -.
DR   UCSC; uc002eil.4; human. [P23141-1]
DR   CTD; 1066; -.
DR   DisGeNET; 1066; -.
DR   GeneCards; CES1; -.
DR   HGNC; HGNC:1863; CES1.
DR   HPA; HPA012023; -.
DR   HPA; HPA046717; -.
DR   MIM; 114835; gene+phenotype.
DR   neXtProt; NX_P23141; -.
DR   OpenTargets; ENSG00000198848; -.
DR   PharmGKB; PA107; -.
DR   eggNOG; KOG1516; Eukaryota.
DR   eggNOG; COG2272; LUCA.
DR   GeneTree; ENSGT00760000118946; -.
DR   HOVERGEN; HBG008839; -.
DR   InParanoid; P23141; -.
DR   KO; K01044; -.
DR   OMA; EYGPACA; -.
DR   OrthoDB; EOG091G03ZC; -.
DR   PhylomeDB; P23141; -.
DR   TreeFam; TF315470; -.
DR   BioCyc; MetaCyc:HS11616-MONOMER; -.
DR   BRENDA; 3.1.1.1; 2681.
DR   Reactome; R-HSA-211945; Phase 1 - Functionalization of compounds.
DR   SABIO-RK; P23141; -.
DR   ChiTaRS; CES1; human.
DR   EvolutionaryTrace; P23141; -.
DR   GeneWiki; Carboxylesterase_1; -.
DR   GenomeRNAi; 1066; -.
DR   PRO; PR:P23141; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000198848; -.
DR   CleanEx; HS_CES1; -.
DR   CleanEx; HS_CES2; -.
DR   ExpressionAtlas; P23141; baseline and differential.
DR   Genevisible; P23141; HS.
DR   GO; GO:0005829; C:cytosol; IEA:GOC.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0052689; F:carboxylic ester hydrolase activity; TAS:Reactome.
DR   GO; GO:0047374; F:methylumbelliferyl-acetate deacetylase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004771; F:sterol esterase activity; IDA:BHF-UCL.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0090122; P:cholesterol ester hydrolysis involved in cholesterol transport; TAS:BHF-UCL.
DR   GO; GO:0030855; P:epithelial cell differentiation; IDA:UniProtKB.
DR   GO; GO:0051791; P:medium-chain fatty acid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0008152; P:metabolic process; TAS:ProtInc.
DR   GO; GO:0009636; P:response to toxic substance; TAS:ProtInc.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:Reactome.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR002018; CarbesteraseB.
DR   InterPro; IPR019826; Carboxylesterase_B_AS.
DR   InterPro; IPR019819; Carboxylesterase_B_CS.
DR   Pfam; PF00135; COesterase; 1.
DR   SUPFAM; SSF53474; SSF53474; 1.
DR   PROSITE; PS00122; CARBOXYLESTERASE_B_1; 1.
DR   PROSITE; PS00941; CARBOXYLESTERASE_B_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Endoplasmic reticulum;
KW   Glycoprotein; Hydrolase; Phosphoprotein; Polymorphism;
KW   Reference proteome; Serine esterase; Signal.
FT   SIGNAL        1     17       {ECO:0000269|PubMed:7980644,
FT                                ECO:0000269|PubMed:9490062}.
FT   CHAIN        18    567       Liver carboxylesterase 1.
FT                                /FTId=PRO_0000391359.
FT   ACT_SITE    221    221       Acyl-ester intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10039,
FT                                ECO:0000269|PubMed:12022871}.
FT   ACT_SITE    354    354       Charge relay system.
FT                                {ECO:0000269|PubMed:12022871}.
FT   ACT_SITE    468    468       Charge relay system.
FT                                {ECO:0000269|PubMed:12022871}.
FT   MOD_RES     380    380       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD     79     79       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12022871}.
FT   DISULFID     87    116
FT   DISULFID    274    285
FT   VAR_SEQ      17     17       W -> WA (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:8218228}.
FT                                /FTId=VSP_021026.
FT   VAR_SEQ     362    362       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_047158.
FT   VARIANT      18     18       G -> GA.
FT                                /FTId=VAR_002357.
FT   VARIANT      75     75       S -> N (in dbSNP:rs2307240).
FT                                /FTId=VAR_014314.
FT   VARIANT     143    143       G -> E (5.4-fold decrease in activity
FT                                with p-nitrophenyl acetate as substrate;
FT                                no change in affinity for p-nitrophenyl
FT                                acetate; loss of activity with L- or D-
FT                                methylphenidate as substrate;
FT                                dbSNP:rs71647871).
FT                                {ECO:0000269|PubMed:18485328}.
FT                                /FTId=VAR_046954.
FT   VARIANT     199    199       R -> H (in dbSNP:rs2307243).
FT                                /FTId=VAR_014594.
FT   VARIANT     203    203       D -> E (in dbSNP:rs2307227).
FT                                /FTId=VAR_014595.
FT   MUTAGEN      79     79       N->A: Abolishes glycosylation.
FT                                {ECO:0000269|PubMed:12022871}.
FT   MUTAGEN     221    221       S->A: Loss of activity.
FT                                {ECO:0000269|PubMed:12022871}.
FT   MUTAGEN     354    354       E->A: Loss of activity.
FT                                {ECO:0000269|PubMed:12022871}.
FT   MUTAGEN     468    468       H->A: Loss of activity.
FT                                {ECO:0000269|PubMed:12022871}.
FT   MUTAGEN     564    567       Missing: Does not result in secretion.
FT                                {ECO:0000269|PubMed:12022871}.
FT   CONFLICT      2      2       W -> L (in Ref. 5; AAD53175).
FT                                {ECO:0000305}.
FT   CONFLICT      4      7       RAFI -> PALV (in Ref. 3; BAA04650, 8;
FT                                BAC87749/BAC87751, 9; BAF83312/BAF84898
FT                                and 11; AAH12418). {ECO:0000305}.
FT   CONFLICT     12     12       S -> A (in Ref. 3; BAA04650, 8; BAC87749/
FT                                BAC87751, 9; BAF83312/BAF84898 and 11;
FT                                AAH12418). {ECO:0000305}.
FT   CONFLICT     19     21       HPS -> GPP (in Ref. 15; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     19     19       H -> N (in Ref. 14; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     21     24       SSPP -> EAVV (in Ref. 14; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     27     28       DT -> AK (in Ref. 14; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     28     29       TV -> DT (in Ref. 15; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     56     56       A -> G (in Ref. 2; AAA16036/AAA35711).
FT                                {ECO:0000305}.
FT   CONFLICT     64     64       R -> G (in Ref. 18; CAA37147).
FT                                {ECO:0000305}.
FT   CONFLICT     65     65       F -> S (in Ref. 6; AAP20868).
FT                                {ECO:0000305}.
FT   CONFLICT     75     75       S -> A (in Ref. 14; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     78     78       K -> I (in Ref. 14; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     89     89       Q -> R (in Ref. 6; AAP20868).
FT                                {ECO:0000305}.
FT   CONFLICT     98     98       S -> F (in Ref. 14; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    105    107       KEN -> PAD (in Ref. 14; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    115    115       D -> H (in Ref. 19; AAA83932).
FT                                {ECO:0000305}.
FT   CONFLICT    186    186       R -> G (in Ref. 18; CAA37147).
FT                                {ECO:0000305}.
FT   CONFLICT    247    247       S -> I (in Ref. 14; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    251    251       L -> K (in Ref. 14; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    253    253       S -> G (in Ref. 14; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    255    255       L -> P (in Ref. 9; BAF83312).
FT                                {ECO:0000305}.
FT   CONFLICT    258    258       K -> Q (in Ref. 14; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    281    281       V -> A (in Ref. 19; AAA83932).
FT                                {ECO:0000305}.
FT   CONFLICT    298    298       T -> I (in Ref. 14; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    302    302       K -> A (in Ref. 14; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    305    305       S -> M (in Ref. 14; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    337    337       A -> R (in Ref. 19; AAA83932).
FT                                {ECO:0000305}.
FT   CONFLICT    417    417       F -> I (in Ref. 19; AAA83932).
FT                                {ECO:0000305}.
FT   CONFLICT    512    512       E -> K (in Ref. 19; AAA83932).
FT                                {ECO:0000305}.
FT   CONFLICT    536    536       A -> G (in Ref. 2; AAA16036/AAA35711).
FT                                {ECO:0000305}.
FT   CONFLICT    563    563       E -> D (in Ref. 19; AAA83932).
FT                                {ECO:0000305}.
FT   STRAND       25     28       {ECO:0000244|PDB:5A7G}.
FT   STRAND       31     34       {ECO:0000244|PDB:5A7G}.
FT   STRAND       36     38       {ECO:0000244|PDB:5A7G}.
FT   STRAND       47     54       {ECO:0000244|PDB:5A7G}.
FT   HELIX        61     63       {ECO:0000244|PDB:5A7G}.
FT   STRAND       75     79       {ECO:0000244|PDB:5A7G}.
FT   STRAND       86     88       {ECO:0000244|PDB:5A7G}.
FT   HELIX        91    101       {ECO:0000244|PDB:5A7G}.
FT   STRAND      104    106       {ECO:0000244|PDB:5A7G}.
FT   STRAND      112    114       {ECO:0000244|PDB:5A7G}.
FT   STRAND      118    123       {ECO:0000244|PDB:5A7G}.
FT   TURN        127    130       {ECO:0000244|PDB:4AB1}.
FT   STRAND      133    139       {ECO:0000244|PDB:5A7G}.
FT   TURN        143    145       {ECO:0000244|PDB:5A7G}.
FT   HELIX       149    151       {ECO:0000244|PDB:5A7G}.
FT   HELIX       155    161       {ECO:0000244|PDB:5A7G}.
FT   STRAND      164    168       {ECO:0000244|PDB:5A7G}.
FT   HELIX       173    177       {ECO:0000244|PDB:5A7G}.
FT   HELIX       183    185       {ECO:0000244|PDB:2HRQ}.
FT   HELIX       189    204       {ECO:0000244|PDB:5A7G}.
FT   HELIX       205    208       {ECO:0000244|PDB:5A7G}.
FT   STRAND      210    220       {ECO:0000244|PDB:5A7G}.
FT   HELIX       222    231       {ECO:0000244|PDB:5A7G}.
FT   HELIX       234    236       {ECO:0000244|PDB:5A7G}.
FT   TURN        237    239       {ECO:0000244|PDB:1MX9}.
FT   STRAND      241    247       {ECO:0000244|PDB:5A7G}.
FT   HELIX       253    255       {ECO:0000244|PDB:5A7G}.
FT   HELIX       262    272       {ECO:0000244|PDB:5A7G}.
FT   HELIX       279    288       {ECO:0000244|PDB:5A7G}.
FT   HELIX       291    301       {ECO:0000244|PDB:5A7G}.
FT   TURN        302    304       {ECO:0000244|PDB:5A7G}.
FT   STRAND      308    310       {ECO:0000244|PDB:5A7G}.
FT   HELIX       312    314       {ECO:0000244|PDB:5A7F}.
FT   STRAND      325    327       {ECO:0000244|PDB:5A7G}.
FT   HELIX       332    338       {ECO:0000244|PDB:5A7G}.
FT   STRAND      339    341       {ECO:0000244|PDB:2H7C}.
FT   STRAND      346    351       {ECO:0000244|PDB:5A7G}.
FT   TURN        352    355       {ECO:0000244|PDB:2HRQ}.
FT   HELIX       358    361       {ECO:0000244|PDB:5A7G}.
FT   TURN        363    365       {ECO:0000244|PDB:1MX9}.
FT   STRAND      369    371       {ECO:0000244|PDB:1MX5}.
FT   HELIX       375    384       {ECO:0000244|PDB:5A7G}.
FT   HELIX       386    389       {ECO:0000244|PDB:5A7G}.
FT   HELIX       393    395       {ECO:0000244|PDB:5A7G}.
FT   HELIX       396    404       {ECO:0000244|PDB:5A7G}.
FT   HELIX       410    425       {ECO:0000244|PDB:5A7G}.
FT   HELIX       427    439       {ECO:0000244|PDB:5A7G}.
FT   STRAND      444    450       {ECO:0000244|PDB:5A7G}.
FT   STRAND      458    460       {ECO:0000244|PDB:1MX5}.
FT   TURN        468    471       {ECO:0000244|PDB:5A7G}.
FT   HELIX       472    475       {ECO:0000244|PDB:5A7G}.
FT   HELIX       478    480       {ECO:0000244|PDB:5A7G}.
FT   HELIX       487    506       {ECO:0000244|PDB:5A7G}.
FT   STRAND      521    523       {ECO:0000244|PDB:2DQZ}.
FT   STRAND      525    532       {ECO:0000244|PDB:5A7G}.
FT   STRAND      534    537       {ECO:0000244|PDB:5A7G}.
FT   HELIX       541    551       {ECO:0000244|PDB:5A7G}.
SQ   SEQUENCE   567 AA;  62521 MW;  D3A00BDCDC7E5DFF CRC64;
     MWLRAFILAT LSASAAWGHP SSPPVVDTVH GKVLGKFVSL EGFAQPVAIF LGIPFAKPPL
     GPLRFTPPQP AEPWSFVKNA TSYPPMCTQD PKAGQLLSEL FTNRKENIPL KLSEDCLYLN
     IYTPADLTKK NRLPVMVWIH GGGLMVGAAS TYDGLALAAH ENVVVVTIQY RLGIWGFFST
     GDEHSRGNWG HLDQVAALRW VQDNIASFGG NPGSVTIFGE SAGGESVSVL VLSPLAKNLF
     HRAISESGVA LTSVLVKKGD VKPLAEQIAI TAGCKTTTSA VMVHCLRQKT EEELLETTLK
     MKFLSLDLQG DPRESQPLLG TVIDGMLLLK TPEELQAERN FHTVPYMVGI NKQEFGWLIP
     MQLMSYPLSE GQLDQKTAMS LLWKSYPLVC IAKELIPEAT EKYLGGTDDT VKKKDLFLDL
     IADVMFGVPS VIVARNHRDA GAPTYMYEFQ YRPSFSSDMK PKTVIGDHGD ELFSVFGAPF
     LKEGASEEEI RLSKMVMKFW ANFARNGNPN GEGLPHWPEY NQKEGYLQIG ANTQAAQKLK
     DKEVAFWTNL FAKKAVEKPP QTEHIEL
//
